The COVID-19 pandemic has spawned global health crisis of unprecedented magnitude,
claiming millions of lives and pushing healthcare systems in many countries to the brink …

Background Some human polymorphisms of ACE1, ACE2, IFITM3, TMPRSS2 and TNFα
genes may have an effect on the susceptibility to SARS-CoV-2 infection and increase the …

Genetic and non-genetic factors are responsible for the high interindividual variability in the
response to SARS-CoV-2. Although numerous genetic polymorphisms have been identified …

The SARS-CoV-2 infection causes COVID-19 disease, characterized by acute respiratory
distress syndrome, bilateral pneumonia, and organ failure. The consequences of maternal …

Recent research has associated the interferon‐induced transmembrane protein 3 gene
(IFITM3) with the outcomes of coronavirus disease 2019 (COVID‐19), although the findings …

Background: Since the beginning of the pandemic of coronavirus disease 2019 (COVID-19),
many countries have experienced a considerable number of COVID-19 cases and deaths …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of
COVID-19, emanated from the Wuhan Province in China and rapidly spread across the …

Our aim was to assess the association between four inflammatory polymorphisms with the
development of post-COVID pain and to associate these polymorphisms with the clinical …

In early 2020, one of the most prevalent symptoms of SARS-CoV-2 infection was the loss of
smell (anosmia), found in 60-70% of all cases. Anosmia used to occur early, concomitantly …

Background Although COVID-19 infection has been associated with a number of clinical and
environmental risk factors, host genetic variation has also been associated with the …